Compound Detail
CHEMBL1185
ZOLMITRIPTAN 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL1185 |
| Name | ZOLMITRIPTAN |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | ULSDMUVEXKOYBU-ZDUSSCGKSA-N |
| Therapeutic | ✓ Yes |
7
Targets
18
Activities
4
Assay Types
21
PK Parameters
20
Publications
7
Known Names
1
Indications
2
Mechanisms
Molecular Properties
287.4
MW (Da)
1.92
ALogP
3
HBA
2
HBD
57.4
PSA (Ų)
0.88
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1997 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Serotonin 1b (5-HT1b) receptor agonist | AGONIST | 5-hydroxytryptamine receptor 1B | ✓ | ✓ |
| Serotonin 1d (5-HT1d) receptor agonist | AGONIST | 5-hydroxytryptamine receptor 1D | ✓ | ✓ |
Indications
Migraine Disorders
ATC Classification
N02CC03
zolmitriptan
Level 1: NERVOUS SYSTEM
Level 2: ANALGESICS
Activity Summary
Ki 8 meas. best 9.4
Kd 6 meas. best 10.4
EC50 2 meas. best 7.8
IC50 2 meas. best 8.55
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| D(2) dopamine receptor CHEMBL339 | Kd | 10.4 | 10.4 | 0.0 | 1 |
| D(1A) dopamine receptor CHEMBL265 | Kd | 9.52 | 9.52 | 0.3 | 1 |
| 5-hydroxytryptamine receptor 1B CHEMBL1898 | Ki | 9.4 | 8.89 | 0.4 | 2 |
| 5-hydroxytryptamine receptor 1D CHEMBL1983 | Ki | 9.4 | 8.99 | 0.4 | 4 |
| 5-hydroxytryptamine receptor 1B CHEMBL1898 | Kd | 8.82 | 8.82 | 1.5 | 1 |
| 5-hydroxytryptamine receptor 1D CHEMBL1983 | Kd | 8.82 | 8.82 | 1.5 | 1 |
| 5-hydroxytryptamine receptor 1A CHEMBL214 | Kd | 8.74 | 8.74 | 1.8 | 1 |
| 5-hydroxytryptamine receptor 1D CHEMBL1983 | IC50 | 8.55 | 8.55 | 2.8 | 1 |
| 5-hydroxytryptamine receptor 1B CHEMBL1898 | IC50 | 8.21 | 8.21 | 6.2 | 1 |
| Adrenergic receptor alpha-2 CHEMBL2093864 | Kd | 8.15 | 8.15 | 7.0 | 1 |
| 5-hydroxytryptamine receptor 1B CHEMBL1898 | EC50 | 7.8 | 7.8 | 15.7 | 1 |
| ADMET CHEMBL612558 | EC50 | 7.4 | 7.4 | 40.0 | 1 |
| 5-hydroxytryptamine receptor 1A CHEMBL214 | Ki | 7.11 | 7.01 | 78.6 | 2 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 6.7 | mL.min-1.kg-1 | Homo sapiens |
| CL | 4.5 | mL.min-1.kg-1 | Homo sapiens |
| CL | 6.7 | mL.min-1.kg-1 | Homo sapiens |
| CL | 6.7 | mL.min-1.kg-1 | Homo sapiens |
| CL | 31.5 | mL.min-1.kg-1 | Homo sapiens |
| Excretion | 8.0 | % | Homo sapiens |
| F | 40.0 | % | Homo sapiens |
| F | 40.0 | % | Homo sapiens |
| F | 40.0 | % | Homo sapiens |
| Fu | 0.75 | - | Homo sapiens |
| Fu | 0.75 | - | Homo sapiens |
| Fu | 0.942 | - | Rattus norvegicus |
| Fu | 1.0 | - | Rattus norvegicus |
| MRT | 4.6 | hr | Homo sapiens |
| PPB | 25.0 | % | Homo sapiens |
| T1/2 | 3.6 | hr | Homo sapiens |
| Tmax | 2.0 | hr | Homo sapiens |
| Tmax | 4.0 | hr | Homo sapiens |
| Tmax | 3.0 | hr | Homo sapiens |
| Tmax | 1.5 | hr | Homo sapiens |
| Vd | 7.0 | L.kg-1 | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine